complications from semaglutide Ozempic (semaglutide) is a GLP-1 receptor agonist used for type 2 diabetes (and sometimes weight loss). Its side effects range common GI symptoms to rare but serious risks. ⸻ 🟡 Common Patel it Like it is:

[(accessed on 15 April 2025)]

[email protected] | To view or add a comment, sign in Novo Nordisk partners with Vivtex in up to $2.1 billion deal for oral obesity drugs: Feb 25 (Reuters) - Danish drugmaker Novo Nordisk has partnered with U.S.-based Vivtex Corp in a deal worth up to $2.1 billion to develop next-generation oral drugs for obesity and diabetes, the #NovoNordisk #Vivtex #ObesityTreatment #DiabetesCare #Pharmaceuticals To view or add a comment, sign in Head-to-head trials are often reserved for approved therapies as drugmakers try to one-up each other to gain further market share

The irritated tissue swells up, and that extra pressure in the small space causes pain

Here are the pros and cons of using GLP-1 antagonists

Its time to move beyond frustrating fad diets and embrace a medical approach to reclaim your physique and your vitality

more liquid to inject